Literature DB >> 6477961

The rate-limiting reaction in phosphatidylcholine synthesis by alveolar type II cells isolated from fetal rat lung.

M Post, J J Batenburg, L M Van Golde, B T Smith.   

Abstract

The rate-limiting reaction in the formation of phosphatidylcholine by type II cells isolated from fetal rat lung was examined. Studies on the uptake of [Me-3H]choline and its incorporation into its metabolites indicated that in these cells the choline phosphate pool was much larger than both the choline and CDPcholine pools. Chemical measurements of the pool sizes showed that the choline phosphate pool was indeed much larger than the intracellular choline and CDPcholine pools. Pulse-chase studies with [Me-3H]choline revealed that labelled choline taken up by the cells was rapidly phosphorylated to choline phosphate and that the radioactivity lost from choline phosphate during the chase period appeared in phosphatidylcholine. Little change was observed in the labelling of CDPcholine during the chase period. These results indicate that cholinephosphate cytidylyltransferase catalyzes a rate-limiting reaction in phosphatidylcholine formation by fetal rat lung type II cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477961     DOI: 10.1016/0005-2760(84)90186-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Maternal administration of dexamethasone stimulates choline-phosphate cytidylyltransferase in fetal type II cells.

Authors:  M Post
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

2.  Regulation of CTP: phosphocholine cytidylyltransferase activity in type II pneumonocytes.

Authors:  M Tesan; M M Anceschi; J E Bleasdale
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

3.  Stimulation of phosphatidylcholine biosynthesis in mouse MLE-12 type-II cells by conditioned medium from cortisol-treated rat fetal lung fibroblasts.

Authors:  J I MacDonald; F Possmayer
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.